Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.100 | ||
| Révision: | $546.90M | $471.70M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.780 | 1.970 | 0.1900 |
| Révision: | $532.29M | $501.90M | $15.21M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.830 | 2.040 | 0.2100 |
| Révision: | $497.39M | $487.80M | $6.91M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.050 | 2.340 | 0.2900 |
| Révision: | $529.93M | $526.60M | $2.87M |
